$55.53 $0.32 (0.6%)

04:15 PM EDT on 04/03/20

Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 5 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Current Price $55.53 Mkt Cap $125.6B
Open $54.99 P/E Ratio 27.53
Prev. Close $55.53 Div. (Yield) $1.72 (3.1%)
Daily Range $54.95 - $56.47 Volume 3,778,090
52-Wk Range $45.77 - $68.34 Avg. Daily Vol. 16,993,465

Caps

How do you think NYSE:BMY will perform against the market?

Add Stock to CAPS Watchlist

All Players

1,772 Outperform
113 Underperform
 

All-Star Players

355 Outperform
16 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:BMY Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

johnclanaro (< 20)
Submitted October 28, 2013

recent upgrade. good pipeline.

msabol01 (59.35)
Submitted April 02, 2017

Strong pipeline and a culture that wants to innovate. Strong focus on patients. Leadership seems to struggle with launching products and being competitive out the door. Long term will either find BMY on strong footing or acquired.

Recent Community Commentary

Read the most recent pitches from players about BMY.

Recs

0
Member Avatar TMFAdriaCimino (75.19) Submitted: 4/2/2020 10:26:43 AM : Outperform Start Price: $54.70 NYSE:BMY Score: +1.45

The earnings potential of the Celgene acquisition adds to earnings potential.

Recs

0
Member Avatar luremaster (26.57) Submitted: 3/21/2020 2:46:52 PM : Outperform Start Price: $48.53 NYSE:BMY Score: +4.90

great company,dirt cheap

Recs

0
Member Avatar Derrick5012 (55.32) Submitted: 3/18/2020 1:30:26 PM : Outperform Start Price: $48.61 NYSE:BMY Score: +7.12

Celgene takeover, drugs outlets

Leaderboard

Find the members with the highest scoring picks in BMY.

Score Leader

d3lta4ce

d3lta4ce (23.28) Score: +255.45

The Score Leader is the player with the highest score across all their picks in BMY.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
99FE905 21.45 6/20/2008 Outperform 5Y $12.68 +337.87% +93.26% +244.61 0 Comment
tkaskmaster 65.17 6/23/2008 Outperform 3M $12.70 +337.41% +93.85% +243.56 0 Comment
SandmanKy 29.85 6/13/2008 5/8/2015 Outperform 5Y $12.79 +334.11% +91.33% +242.78 1 Comment
tylerfu 69.87 6/13/2008 Outperform 5Y $12.79 +334.11% +91.33% +242.78 0 Comment
CLF65 27.43 6/24/2008 9/8/2009 Outperform 1Y $12.68 +337.87% +95.21% +242.66 0 Comment
Nacho2k 78.19 6/13/2008 Outperform 3Y $12.86 +331.72% +89.37% +242.35 0 Comment
cyberDEAD < 20 6/20/2008 Outperform 1Y $12.77 +334.78% +92.56% +242.21 0 Comment
snowape 72.20 6/18/2008 Outperform 3Y $12.79 +334.22% +92.08% +242.14 1 Comment
tnovosad < 20 6/13/2008 Outperform NS $12.88 +331.29% +89.19% +242.10 0 Comment
bigbird0459 < 20 6/11/2008 Outperform NS $12.86 +331.93% +90.52% +241.41 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BMY.